JP2012102106A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012102106A5 JP2012102106A5 JP2011266396A JP2011266396A JP2012102106A5 JP 2012102106 A5 JP2012102106 A5 JP 2012102106A5 JP 2011266396 A JP2011266396 A JP 2011266396A JP 2011266396 A JP2011266396 A JP 2011266396A JP 2012102106 A5 JP2012102106 A5 JP 2012102106A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- lower alkyl
- structures
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 60
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 31
- 125000000217 alkyl group Chemical group 0.000 claims 28
- 229910052717 sulfur Inorganic materials 0.000 claims 19
- 239000002184 metal Substances 0.000 claims 14
- 229910052751 metal Inorganic materials 0.000 claims 14
- 238000001514 detection method Methods 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 125000001424 substituent group Chemical group 0.000 claims 11
- 238000001727 in vivo Methods 0.000 claims 9
- 238000000034 method Methods 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 9
- 208000024827 Alzheimer disease Diseases 0.000 claims 8
- 208000037259 Amyloid Plaque Diseases 0.000 claims 8
- 210000004556 brain Anatomy 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000000243 solution Substances 0.000 claims 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 6
- 210000001638 cerebellum Anatomy 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 231100000252 nontoxic Toxicity 0.000 claims 6
- 230000003000 nontoxic effect Effects 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 4
- 150000001412 amines Chemical group 0.000 claims 4
- 238000001574 biopsy Methods 0.000 claims 3
- 239000013522 chelant Substances 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 238000003384 imaging method Methods 0.000 claims 3
- 238000002372 labelling Methods 0.000 claims 3
- 210000005013 brain tissue Anatomy 0.000 claims 2
- 238000010494 dissociation reaction Methods 0.000 claims 2
- 230000005593 dissociations Effects 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 238000011503 in vivo imaging Methods 0.000 claims 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 2
- 238000000386 microscopy Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- 108700028369 Alleles Proteins 0.000 claims 1
- 108010060159 Apolipoprotein E4 Proteins 0.000 claims 1
- 201000010374 Down Syndrome Diseases 0.000 claims 1
- 206010044688 Trisomy 21 Diseases 0.000 claims 1
- 239000012062 aqueous buffer Substances 0.000 claims 1
- 238000000339 bright-field microscopy Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000004624 confocal microscopy Methods 0.000 claims 1
- 238000005388 cross polarization Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 208000025688 early-onset autosomal dominant Alzheimer disease Diseases 0.000 claims 1
- 208000015756 familial Alzheimer disease Diseases 0.000 claims 1
- 238000000799 fluorescence microscopy Methods 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 238000002595 magnetic resonance imaging Methods 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 238000002603 single-photon emission computed tomography Methods 0.000 claims 1
- 238000004611 spectroscopical analysis Methods 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 0 Cc(c(*)c1[U]=C(*)*c1c1*)c1O* Chemical compound Cc(c(*)c1[U]=C(*)*c1c1*)c1O* 0.000 description 15
- OFRURSUYKRVAQS-UHFFFAOYSA-N CCC1N(CCS)N2SCCN2C1 Chemical compound CCC1N(CCS)N2SCCN2C1 OFRURSUYKRVAQS-UHFFFAOYSA-N 0.000 description 2
- OZSUSCPBERDFQY-UHFFFAOYSA-N CC(N(CCNCCS)CCS)=O Chemical compound CC(N(CCNCCS)CCS)=O OZSUSCPBERDFQY-UHFFFAOYSA-N 0.000 description 1
- NIVJWZHZUYGOFO-UHFFFAOYSA-N CCC(CNCCS)NCCS Chemical compound CCC(CNCCS)NCCS NIVJWZHZUYGOFO-UHFFFAOYSA-N 0.000 description 1
- GVADEGSGOIMUBR-UHFFFAOYSA-N CCCC(CNCCS)NCCS Chemical compound CCCC(CNCCS)NCCS GVADEGSGOIMUBR-UHFFFAOYSA-N 0.000 description 1
- BKEWUPYQZGSANF-UHFFFAOYSA-N CN(CCNCCS)CCS Chemical compound CN(CCNCCS)CCS BKEWUPYQZGSANF-UHFFFAOYSA-N 0.000 description 1
- MGVYMPNUYPIBQI-UHFFFAOYSA-N C[N]1(CCS)N(SC)SCC1 Chemical compound C[N]1(CCS)N(SC)SCC1 MGVYMPNUYPIBQI-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22760100P | 2000-08-24 | 2000-08-24 | |
| US60/227,601 | 2000-08-24 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002521434A Division JP5022554B2 (ja) | 2000-08-24 | 2001-08-24 | アルツハイマー病の生前診断ならびにアミロイド沈着物のインビボ画像化および予防に用いるためのチオフラビン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012102106A JP2012102106A (ja) | 2012-05-31 |
| JP2012102106A5 true JP2012102106A5 (Direct) | 2013-03-21 |
Family
ID=22853739
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002521434A Expired - Lifetime JP5022554B2 (ja) | 2000-08-24 | 2001-08-24 | アルツハイマー病の生前診断ならびにアミロイド沈着物のインビボ画像化および予防に用いるためのチオフラビン誘導体 |
| JP2011266396A Pending JP2012102106A (ja) | 2000-08-24 | 2011-12-06 | アルツハイマー病の生前診断ならびにアミロイド沈着物のインビボ画像化および予防に用いるためのチオフラビン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002521434A Expired - Lifetime JP5022554B2 (ja) | 2000-08-24 | 2001-08-24 | アルツハイマー病の生前診断ならびにアミロイド沈着物のインビボ画像化および予防に用いるためのチオフラビン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US20020133019A1 (Direct) |
| EP (2) | EP2264018B1 (Direct) |
| JP (2) | JP5022554B2 (Direct) |
| CN (1) | CN1285582C (Direct) |
| AU (3) | AU8670201A (Direct) |
| BR (1) | BRPI0113470B8 (Direct) |
| CA (1) | CA2419420C (Direct) |
| CY (1) | CY1113311T1 (Direct) |
| DK (2) | DK2264018T3 (Direct) |
| ES (2) | ES2395721T3 (Direct) |
| HU (2) | HU230375B1 (Direct) |
| LT (1) | LTC1334091I2 (Direct) |
| NO (1) | NO330176B1 (Direct) |
| PL (1) | PL215711B1 (Direct) |
| PT (2) | PT2264018E (Direct) |
| RU (1) | RU2324686C2 (Direct) |
| SI (1) | SI1334091T1 (Direct) |
| WO (1) | WO2002016333A2 (Direct) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10604516B2 (en) | 2012-12-21 | 2020-03-31 | National Institutes For Quantum And Radiological Science And Technology | Compounds for imaging tau proteins that accumulate in the brain |
Families Citing this family (114)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6689753B1 (en) * | 1999-11-05 | 2004-02-10 | Axonyx, Inc. | β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide |
| AU2001239544A1 (en) * | 2000-03-22 | 2001-10-03 | Bf Research Institute, Inc. | Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same |
| AU8517001A (en) | 2000-08-21 | 2002-03-04 | Gen Hospital Corp | Methods for diagnosing a neurodegenerative condition |
| US7297326B2 (en) * | 2000-08-21 | 2007-11-20 | The General Hospital Corporation | Ocular diagnosis of Alzheimer's disease |
| DK2264018T3 (en) | 2000-08-24 | 2015-05-11 | Univ Pittsburgh | Thioflavin derivatives for use in diagnosis of Alzheimer's disease |
| US7270800B2 (en) | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| ATE360392T1 (de) * | 2000-11-02 | 2007-05-15 | Cornell Res Foundation Inc | In vivo multiphoton diagnostische detektion und bilddarstellung einer neurodegenerativen erkrankung |
| JP2004524289A (ja) * | 2000-12-22 | 2004-08-12 | アストラゼネカ・アクチエボラーグ | 治療化合物 |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| AU2002353739A1 (en) * | 2001-11-28 | 2003-06-10 | Astrazeneca Ab | Therapeutic compounds |
| US6774248B2 (en) | 2001-12-18 | 2004-08-10 | Wyeth | Substituted 2-phenyl benzofurans as estrogenic agents |
| EP1820806A1 (en) * | 2006-02-16 | 2007-08-22 | Crossbeta Biosciences B.V. | Affinity regions |
| AU2003239508A1 (en) | 2002-05-21 | 2003-12-12 | Bristol-Myers Squibb Company | Indole compounds useful as impdh inhibitors |
| WO2003106439A1 (ja) * | 2002-06-12 | 2003-12-24 | 株式会社ビーエフ研究所 | アミロイド蓄積性疾患の画像診断プローブ化合物、老人斑／びまん性老人斑染色用化合物、ならびにアミロイド蓄積性疾患の治療薬 |
| US20070003552A1 (en) * | 2002-07-09 | 2007-01-04 | Gebbink Martijn F B | Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation |
| EP1380290A1 (en) * | 2002-07-09 | 2004-01-14 | Universitair Medisch Centrum Utrecht | Cross-beta structure pathway and its therapeutic relevance |
| WO2004035522A1 (ja) * | 2002-08-30 | 2004-04-29 | Bf Research Institute, Inc. | プリオン蛋白蓄積性疾患の診断プローブおよび治療薬ならびにプリオン蛋白の染色剤 |
| JP4665076B2 (ja) | 2002-12-19 | 2011-04-06 | ザ スクリプス リサーチ インスティチュート | トランスチレチンの安定化及びトランスチレチンの誤った折り畳みの阻害のための組成物及び方法 |
| GB0229686D0 (en) * | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase fluorination of benzothiazoles |
| CA2438032C (en) * | 2003-03-14 | 2013-05-07 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
| RU2440995C2 (ru) * | 2003-03-14 | 2012-01-27 | Юнивесити Оф Питсбэг | Производные бензотиазола, фармацевтическая композиция, обладающая свойством связывать амилоид, и способ детекции отложений амилоида у млекопитающего |
| GB0307855D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Organic compounds |
| EP1631561B1 (en) | 2003-05-07 | 2010-08-18 | General Electric Company | Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| US20040223912A1 (en) * | 2003-05-07 | 2004-11-11 | Montalto Michael Christopher | Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| WO2005016888A1 (ja) * | 2003-08-13 | 2005-02-24 | Bf Research Institute, Inc. | アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤 |
| AU2003304416A1 (en) * | 2003-08-13 | 2005-03-07 | Bf Research Institute, Inc. | Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| US8236282B2 (en) | 2003-08-22 | 2012-08-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Benzothiazole derivative compounds, compositions and uses |
| JP3877754B2 (ja) * | 2003-10-30 | 2007-02-07 | 株式会社同仁化学研究所 | アミロイド親和性化合物 |
| EP1719529A4 (en) * | 2004-02-25 | 2008-05-21 | Astellas Pharma Inc | CONTRASTING FOR THROMBUS EDUCATION |
| CN1953967B (zh) | 2004-04-27 | 2013-03-13 | 惠氏公司 | 孕酮受体调节剂的纯化 |
| GB0410448D0 (en) | 2004-05-11 | 2004-06-16 | Hammersmith Imanet Ltd | Purification methods |
| CN101198598A (zh) | 2004-05-20 | 2008-06-11 | 弗尔德里克斯制药股份有限公司 | 2-((杂)芳基)-苯并噁唑化合物及其衍生物、组合物以及用于稳定和抑制甲状腺素转运蛋白错重叠的方法 |
| BRPI0512932A (pt) * | 2004-07-02 | 2008-04-15 | Univ Pittsburgh | compostos e métodos de identificação e de diagnóstico de paciente como prodrÈmico para doença associada com a deposição amilóide |
| AU2005270026A1 (en) | 2004-07-02 | 2006-02-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Use of thioflavin radiolabeled derivatives in amyloid imaging for assessing anti-amyloid therapies |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| EP1771169A1 (en) | 2004-07-14 | 2007-04-11 | PTC Therapeutics, Inc. | Methods for treating hepatitis c |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US20090087376A1 (en) * | 2004-07-15 | 2009-04-02 | The General Hospital Corporation | Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease |
| CA2578636A1 (en) | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
| ATE554394T1 (de) * | 2005-07-13 | 2012-05-15 | Crossbeta Biosciences Bv | Cross-beta-struktur-bindende verbindungen |
| US20070015133A1 (en) * | 2005-07-13 | 2007-01-18 | Umc Utrecht Holding B.V. | Method for detecting and/or removing protein and/or peptide comprising a cross-beta structure from an aqueous solution comprising a protein |
| US8114832B2 (en) * | 2005-07-13 | 2012-02-14 | Crossbeta Biosciences B.V. | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition |
| CN101262881A (zh) * | 2005-07-13 | 2008-09-10 | 交叉β生物科学有限公司 | 通过交叉β结构的佐剂化 |
| EP1937260A2 (en) * | 2005-09-16 | 2008-07-02 | University of Pittsburgh | In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| KR100778888B1 (ko) * | 2005-11-29 | 2007-11-28 | 재단법인서울대학교산학협력재단 | 베타아밀로이드 펩타이드 플라크의 영상화를 위한벤질리덴아닐린 계열의 유도체 및 그의 방사성 동위원소표지화합물 |
| EP1956013B1 (en) * | 2005-11-30 | 2016-04-13 | Fujifilm RI Pharma Co., Ltd. | Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| CA2631905A1 (en) * | 2005-12-01 | 2007-06-07 | William E. Klunk | Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
| WO2007075595A2 (en) * | 2005-12-20 | 2007-07-05 | Vertex Pharmacueticals Incorporated | Biofilm assay |
| US7781187B2 (en) * | 2005-12-30 | 2010-08-24 | Corning Incorporated | Fluorescent dyes |
| TW200736252A (en) | 2006-01-27 | 2007-10-01 | Astrazeneca Ab | Novel heteroaryl substituted benzothiazoles |
| JP5376956B2 (ja) | 2006-02-10 | 2013-12-25 | スムミト コーポレーション ピーエルシー | デュシェンヌ型筋ジストロフィーの治療 |
| WO2007111179A1 (ja) * | 2006-03-28 | 2007-10-04 | Shiga University Of Medical Science | 神経難病の画像診断薬 |
| TW200803903A (en) | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
| EP2023919A4 (en) * | 2006-05-08 | 2010-12-22 | Molecular Neuroimaging Llc | COMPOUNDS AND AMYLOID PROBES FOR THERAPY AND IMAGING USES |
| TW200808795A (en) | 2006-05-19 | 2008-02-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity for amyloid |
| TW200813035A (en) | 2006-06-19 | 2008-03-16 | Astrazeneca Ab | Novel heteroaryl substituted benzoxazoles |
| KR20090025282A (ko) | 2006-06-21 | 2009-03-10 | 니혼 메디피직스 가부시키가이샤 | 신규 아밀로이드 친화성 화합물 |
| EP2059491A1 (en) * | 2006-08-03 | 2009-05-20 | Hammersmith Imanet Limited | Method for the purification of radiolabelled compounds |
| WO2008065785A1 (en) | 2006-11-30 | 2008-06-05 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
| CN101668560A (zh) * | 2006-12-07 | 2010-03-10 | 宾夕法尼亚大学理事会 | 乙炔衍生物及它们在结合和显像淀粉样斑块中的应用 |
| EP2126609B1 (en) * | 2007-01-30 | 2013-03-27 | GE Healthcare Limited | Tools for aiding in the diagnosis of neurodegenerative diseases |
| US8343459B2 (en) | 2007-02-13 | 2013-01-01 | Nihon Medi-Physics Co., Ltd. | Method for production of radiation diagnostic imaging agent |
| TW200901998A (en) | 2007-03-06 | 2009-01-16 | Astrazeneca Ab | Novel 2-heteroaryl substituted benzothiophenes and benzofuranes |
| CN101293878B (zh) * | 2007-04-25 | 2010-12-15 | 中国科学院上海应用物理研究所 | 苯并噻唑苯胺类化合物及其制备方法和应用 |
| CA2685540C (en) | 2007-08-03 | 2018-10-16 | Graham Michael Wynne | Drug combinations for the treatment of duchenne muscular dystrophy |
| WO2009027452A2 (en) | 2007-08-30 | 2009-03-05 | Ge Healthcare Limited | Radiopharmaceutical composition |
| CA2703649A1 (en) | 2007-10-24 | 2009-04-30 | Shigeyuki Tanifuji | Novel compound having affinity for amyloid |
| US8399672B2 (en) | 2007-10-26 | 2013-03-19 | Nihon Medi-Physics Co., Ltd. | Compound having affinity for amyloid |
| EP2216051A1 (en) * | 2007-10-30 | 2010-08-11 | Nihon Medi-Physics Co., Ltd. | Use of novel compound having affinity for amyloid, and process for production of the same |
| TW200922629A (en) | 2007-10-30 | 2009-06-01 | Nihon Mediphysics Co Ltd | Utilization of novel compounds with amyloid affinity and method of producing the same |
| US20090123373A1 (en) * | 2007-11-05 | 2009-05-14 | Yanming Wang | Amyloid-imaging agents |
| EP2058000A1 (en) * | 2007-11-08 | 2009-05-13 | Crossbeta Biosciences B.V. | Immunogenic compositions capable of activating T cells |
| EP2058001A1 (en) * | 2007-11-08 | 2009-05-13 | Crossbeta Biosciences B.V. | Enhancement of immunogenicity of antigens |
| CA2725940A1 (en) | 2008-05-30 | 2009-12-23 | Merck Sharp & Dohme Corp. | Novel substituted azabenzoxazoles |
| JP2011521959A (ja) * | 2008-05-30 | 2011-07-28 | メルク・シャープ・エンド・ドーム・コーポレイション | 新規な置換されたインドール |
| EP2304366A2 (en) * | 2008-05-30 | 2011-04-06 | Foster Wheeler Energia Oy | Method of and system for generating power by oxyfuel combustion |
| HUE053352T2 (hu) | 2008-06-09 | 2021-06-28 | Univ Muenchen Ludwig Maximilians | Új hatóanyagok fehérje-aggregációval kapcsolatos betegségeknél és/vagy neurodegeneratív betegségeknél szerepet játszó fehérjék aggregációjának gátlására |
| US20100099609A1 (en) * | 2008-07-28 | 2010-04-22 | Buck Institute For Age Research | eAPP AND DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE |
| EP2344877A4 (en) | 2008-09-30 | 2014-09-10 | Univ Case Western Reserve | MOLECULAR SOLIDS FOR IMAGING MYELIN |
| AU2008363871B2 (en) * | 2008-11-06 | 2012-06-07 | Snu R&Db Foundation | Fluorinated benzothiazole derivatives, preparation method thereof and imaging agent for diagnosing Altzheimer's disease using the same |
| US20100129290A1 (en) * | 2008-11-26 | 2010-05-27 | I.S.T. Corporation | Smart contrast agent and detection method for detecting transition metal ions |
| CN101598703B (zh) * | 2009-07-03 | 2012-08-22 | 中国人民解放军第三军医大学第一附属医院 | dGTpase蛋白在制备用于鉴别诊断唐氏胎儿药物中的应用 |
| FR2948685A1 (fr) * | 2009-07-30 | 2011-02-04 | Biomerieux Sa | Nouveaux substrats |
| US20110081428A1 (en) * | 2009-09-16 | 2011-04-07 | The Buck Institute For Age Research | Use of thioflavin-like compounds to increase life span and/or health span |
| DE102010045797A1 (de) | 2010-09-20 | 2012-03-22 | Klinikum Darmstadt Gmbh | Verbindungen für die Diagnostik neurodegenerativer Erkrankungen am Riechepithel |
| WO2012041292A2 (de) | 2010-09-20 | 2012-04-05 | Klinikum Darmstadt Gmbh | Verbindungen für die diagnostik neurodegenerativer erkrankungen an der retina |
| EP2716641B1 (en) | 2011-05-20 | 2017-04-05 | Nihon Medi-Physics Co., Ltd. | Radioactive iodine labeled compound having affinity for amyloid |
| ES2619830T3 (es) | 2011-06-24 | 2017-06-27 | Nihon Medi-Physics Co., Ltd. | Nuevo compuesto con afinidad por amiloide |
| WO2013027694A1 (ja) * | 2011-08-24 | 2013-02-28 | 国立大学法人京都大学 | コンフォメーション病診断用分子イメージングプローブ |
| AU2012310157B2 (en) | 2011-09-16 | 2015-11-12 | Pfizer Inc. | Solid forms of a transthyretin dissociation inhibitor |
| CN102526765B (zh) * | 2011-12-31 | 2014-07-30 | 郑州泰基鸿诺药物科技有限公司 | 一种Aβ斑块显像剂及其制备方法 |
| KR20130111082A (ko) * | 2012-03-30 | 2013-10-10 | 한미약품 주식회사 | 베타-아밀로이드 피브릴 형성 저해 효능을 갖는 아미노스티릴벤조퓨란 화합물 및 이를 함유하는 약학 조성물 |
| WO2014032732A1 (de) | 2012-08-28 | 2014-03-06 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Halogenierte benzoxazine und ihre verwendung |
| EP2890700B1 (de) * | 2012-08-28 | 2017-12-13 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Halogenierte benzoxazine und ihre verwendung |
| US9246108B2 (en) | 2012-12-28 | 2016-01-26 | Dow Global Technologies Llc | Quinoline-benzoxazole derived compounds for electronic films and devices |
| WO2014127365A1 (en) | 2013-02-15 | 2014-08-21 | Case Western Reserve University | Psma ligands and uses thereof |
| CA2920068A1 (en) | 2013-09-26 | 2015-04-02 | F. Hoffmann-La Roche Ag | Imidazo[1,2-a]pyridin-7-amines as imaging tools |
| WO2015051188A1 (en) | 2013-10-02 | 2015-04-09 | Washington University | Heterocyclic molecules for biomedical imaging and therapeutic applications |
| EP4039255B1 (en) | 2014-04-24 | 2025-10-15 | Omoidesouzou Co. Ltd. | Amyloid fiber formation limiter or inhibitor |
| CN104059028B (zh) * | 2014-06-06 | 2020-10-16 | 北京智博高科生物技术有限公司 | 与Aβ斑块具有亲和力的含手性侧链取代的氟代2-芳基苯并杂环化合物、其制备方法及应用 |
| JP6498412B2 (ja) * | 2014-10-17 | 2019-04-10 | 国立大学法人群馬大学 | 新規チオフラビンｔ誘導体及びその利用 |
| US9842938B2 (en) | 2015-03-24 | 2017-12-12 | Semiconductor Energy Laboratory Co., Ltd. | Semiconductor device and display device including semiconductor device |
| WO2017156303A1 (en) | 2016-03-09 | 2017-09-14 | Case Western Reserve University | Radioligands for myelin |
| KR20240036709A (ko) * | 2016-03-11 | 2024-03-20 | 에이씨 이뮨 에스에이 | 진단 및 치료를 위한 바이사이클릭 화합물 |
| WO2018062588A1 (ko) | 2016-09-29 | 2018-04-05 | 한국원자력연구원 | 커큐민 유도체, 이의 제조방법 및 이를 포함하는 베타-아밀로이드 플라크 검출용 광음향 영상화제 |
| LT3781561T (lt) | 2018-04-18 | 2024-07-10 | Constellation Pharmaceuticals, Inc. | Metilą modifikuojančių fermentų moduliatoriai, kompozicijos ir jų naudojimas |
| US11167283B2 (en) | 2018-05-04 | 2021-11-09 | University Of South Carolina | Dot blot box and use thereof |
| CN112384517B (zh) | 2018-05-09 | 2023-07-14 | 新旭生技股份有限公司 | 杂芳基化合物及其用途 |
| WO2019226491A1 (en) | 2018-05-21 | 2019-11-28 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| WO2020160332A1 (en) * | 2019-01-31 | 2020-08-06 | Spinogenix, Inc. | Solid forms of a promoter of spinogenesis |
| PE20220562A1 (es) | 2019-07-24 | 2022-04-13 | Constellation Pharmaceuticals Inc | Formas cristalinas de 7-cloro-2-(4-(3-metoxiazetidin-1-il)ciclohexil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-oxo-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioxol-5-carboxamida |
| CA3161455A1 (en) | 2019-11-13 | 2021-05-20 | Aprinoia Therapeutics Limited | Compounds for degrading tau protein aggregates and uses thereof |
| KR102426160B1 (ko) | 2020-07-13 | 2022-07-29 | (주)바이오액츠 | 알츠하이머 진단용 신규 형광화합물 및 이의 제조방법 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA241942A (en) | 1924-08-05 | Martinetto Vittorio | Asynchronous machine | |
| US2715629A (en) * | 1952-07-16 | 1955-08-16 | Du Pont | Sulfonic acid derivatives of 2-(4'-dialkylaminophenyl)-benzothiazole |
| BE581862A (Direct) * | 1958-08-22 | |||
| DE3148291A1 (de) * | 1981-12-05 | 1983-06-09 | Basf Ag, 6700 Ludwigshafen | Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
| DE3307364A1 (de) * | 1983-03-02 | 1984-09-06 | Hoechst Ag, 6230 Frankfurt | Zweikomponenten-diazontypiematerial |
| US4666829A (en) | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
| US4933156A (en) * | 1987-04-08 | 1990-06-12 | Salutar, Inc. | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor |
| JPS63290858A (ja) * | 1987-04-08 | 1988-11-28 | サルター・インコーポレーテツド | アミロイド症及びアルツハイマー病の診断分析法及びそのための試薬 |
| US5231000A (en) | 1987-10-08 | 1993-07-27 | The Mclean Hospital | Antibodies to A4 amyloid peptide |
| CA1339014C (en) | 1987-10-08 | 1997-03-25 | Ronald E. Majocha | Antibodies to a4 amyloid peptide |
| US5297562A (en) | 1991-04-01 | 1994-03-29 | President And Fellows Of Harvard College | Method for detecting and treating Alzheimer's disease |
| US5434050A (en) | 1991-08-13 | 1995-07-18 | Regents Of The University Of Minnesota | Labelled β-amyloid peptide and methods of screening for Alzheimer's disease |
| GB9317949D0 (en) * | 1993-08-28 | 1993-10-13 | Stevens Malcolm F G | Benzothiazole compounds |
| AU692237B2 (en) * | 1994-02-03 | 1998-06-04 | Picower Institute For Medical Research, The | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
| US6417178B1 (en) * | 1994-07-19 | 2002-07-09 | University Of Pittsburgh | Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
| US6168776B1 (en) * | 1994-07-19 | 2001-01-02 | University Of Pittsburgh | Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| WO1996034853A1 (en) | 1995-05-01 | 1996-11-07 | University Of Pittsburgh | Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| GB9503946D0 (en) * | 1995-02-28 | 1995-04-19 | Cancer Res Campaign Tech | Benzazole compounds |
| US6001331A (en) | 1996-01-24 | 1999-12-14 | Warner-Lambert Company | Method of imaging amyloid deposits |
| AU4988997A (en) * | 1996-10-23 | 1998-05-15 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
| HUP0001383A3 (en) | 1996-11-22 | 2001-11-28 | Lilly Co Eli | N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same and their use |
| CA2310330A1 (en) * | 1997-11-20 | 1999-06-03 | Teijin Limited | Biphenylamidine derivatives |
| AU1089900A (en) | 1998-06-30 | 2000-01-24 | Kevin Mcclung | Controlled-penetration projectile |
| JP3820037B2 (ja) * | 1998-11-05 | 2006-09-13 | 三井化学株式会社 | 光記録媒体 |
| GB9919673D0 (en) | 1999-08-20 | 1999-10-20 | Cancer Res Campaign Tech | 2-Arlybenzazole compounds |
| DK2264018T3 (en) * | 2000-08-24 | 2015-05-11 | Univ Pittsburgh | Thioflavin derivatives for use in diagnosis of Alzheimer's disease |
| US7270800B2 (en) * | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| JP2004524289A (ja) | 2000-12-22 | 2004-08-12 | アストラゼネカ・アクチエボラーグ | 治療化合物 |
| CA2444214A1 (en) | 2001-04-23 | 2002-10-31 | The Trustees Of The University Of Pennsylvania | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| GB0229686D0 (en) | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase fluorination of benzothiazoles |
| RU2440995C2 (ru) * | 2003-03-14 | 2012-01-27 | Юнивесити Оф Питсбэг | Производные бензотиазола, фармацевтическая композиция, обладающая свойством связывать амилоид, и способ детекции отложений амилоида у млекопитающего |
| US8236282B2 (en) * | 2003-08-22 | 2012-08-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Benzothiazole derivative compounds, compositions and uses |
| AU2005270026A1 (en) * | 2004-07-02 | 2006-02-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Use of thioflavin radiolabeled derivatives in amyloid imaging for assessing anti-amyloid therapies |
| PT1945622E (pt) * | 2005-10-11 | 2012-04-09 | Univ Pittsburgh | Compostos de benzofurano marcados isotopicamente enquanto agentes de imagiologia para proteínas amilóides |
-
2001
- 2001-08-24 DK DK10185669.8T patent/DK2264018T3/en active
- 2001-08-24 US US09/935,767 patent/US20020133019A1/en not_active Abandoned
- 2001-08-24 HU HU0302956A patent/HU230375B1/hu unknown
- 2001-08-24 AU AU8670201A patent/AU8670201A/xx active Pending
- 2001-08-24 CN CNB018178847A patent/CN1285582C/zh not_active Expired - Lifetime
- 2001-08-24 HU HU1500560A patent/HU230581B1/hu unknown
- 2001-08-24 JP JP2002521434A patent/JP5022554B2/ja not_active Expired - Lifetime
- 2001-08-24 CA CA2419420A patent/CA2419420C/en not_active Expired - Lifetime
- 2001-08-24 SI SI200131017T patent/SI1334091T1/sl unknown
- 2001-08-24 RU RU2003108256/04A patent/RU2324686C2/ru not_active IP Right Cessation
- 2001-08-24 DK DK01966165.1T patent/DK1334091T3/da active
- 2001-08-24 ES ES01966165T patent/ES2395721T3/es not_active Expired - Lifetime
- 2001-08-24 EP EP10185669.8A patent/EP2264018B1/en not_active Expired - Lifetime
- 2001-08-24 PT PT101856698T patent/PT2264018E/pt unknown
- 2001-08-24 WO PCT/US2001/026427 patent/WO2002016333A2/en not_active Ceased
- 2001-08-24 ES ES10185669.8T patent/ES2536449T3/es not_active Expired - Lifetime
- 2001-08-24 AU AU2001286702A patent/AU2001286702B2/en not_active Expired
- 2001-08-24 BR BR0113470-1 patent/BRPI0113470B8/pt not_active IP Right Cessation
- 2001-08-24 PL PL360550A patent/PL215711B1/pl unknown
- 2001-08-24 EP EP01966165A patent/EP1334091B1/en not_active Expired - Lifetime
- 2001-08-24 PT PT1966165T patent/PT1334091E/pt unknown
-
2003
- 2003-02-24 NO NO20030860A patent/NO330176B1/no not_active IP Right Cessation
-
2004
- 2004-06-03 US US10/859,600 patent/US7351401B2/en not_active Expired - Lifetime
-
2008
- 2008-03-11 US US12/046,070 patent/US20080154042A1/en not_active Abandoned
- 2008-06-13 AU AU2008202626A patent/AU2008202626B9/en not_active Expired
-
2011
- 2011-12-02 US US13/310,243 patent/US20120095235A1/en not_active Abandoned
- 2011-12-06 JP JP2011266396A patent/JP2012102106A/ja active Pending
-
2012
- 2012-11-06 CY CY20121101055T patent/CY1113311T1/el unknown
-
2015
- 2015-01-13 US US14/595,949 patent/US9833458B2/en not_active Expired - Fee Related
- 2015-01-19 LT LTPA2015001C patent/LTC1334091I2/lt unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10604516B2 (en) | 2012-12-21 | 2020-03-31 | National Institutes For Quantum And Radiological Science And Technology | Compounds for imaging tau proteins that accumulate in the brain |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012102106A5 (Direct) | ||
| JP2004506723A5 (Direct) | ||
| RU2003108256A (ru) | Производные тиофлавина, связывающие амилоид (варианты), и способ их получения (варианты), фармацевтическая композиция для визуализации in vivo отложений амилоида, способ обнаружения отложений амилоида (варианты), способ определения количества амилоида в биоптате или полученной посмертно ткани, спосооб распознавания боолезни альцгеймера | |
| RU2324686C2 (ru) | ПРОИЗВОДНЫЕ ТИОФЛАВИНА, СВЯЗЫВАЮЩИЕ АМИЛОИД, СПОСОБ ОБНАРУЖЕНИЯ in vivo ОТЛОЖЕНИЙ АМИЛОИДА И СПОСОБ РАСПОЗНАВАНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА | |
| US12419976B2 (en) | Hybrid tracers for targeted cancer imaging and treatment | |
| US20140248213A1 (en) | Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties | |
| JP6722663B2 (ja) | マクロファージおよび他のマンノース結合ｃ型レクチン受容体高発現細胞を標的化するための化合物および組成物、ならびにそれらを使用して治療するおよび診断する方法 | |
| JP5595903B2 (ja) | １８ｆ標識葉酸 | |
| US9040021B2 (en) | Heterocyclic compounds as imaging probes of tau pathology | |
| CN103561776B (zh) | 放射性标记的谷氨酰胺酰环化酶抑制剂 | |
| JP2009528271A5 (Direct) | ||
| CA2974634A1 (en) | Compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells | |
| RU2007104107A (ru) | Тиофлавиновые производные, являющиеся суррогатными маркерами амилоидных отложений (варианты), способ определения эффективности терапевтического лечения амилоидоза (варианты) и способ выявления пациента, находящегося в продромальной стадии заболевания, ассоциированного с отложением амилоида | |
| RU2006107563A (ru) | Зонды для заболеваний с накоплением амилоида, красители для амилоида, лекарства для лечения и профилактики заболеваний с накоплением амилоида, зонды для диагностики нейрофибриллярных клубков и красители для нейрофибриллярных клубков | |
| WO2016011419A1 (en) | Compositions for targeting macrophages and other cd206 high expressing cells and methods of treating and diagnosis | |
| CN102137849A (zh) | 用于结合磷脂酰丝氨酸的环多胺 | |
| EP1655287A1 (en) | Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change | |
| JP7114074B2 (ja) | 画像化のためのニトロキシドを含むアミロイド結合剤およびその治療的使用 | |
| KR20230086657A (ko) | 프로그램된 사멸 리간드-1(pd-li) 발현의 영상화 및 표적화 | |
| CN102557969A (zh) | 环酮类衍生物及其作为淀粉样蛋白沉积物和神经纤维缠结的显像剂和聚集抑制剂的用途 | |
| JPWO2008068974A1 (ja) | オーロン誘導体含有診断用組成物 | |
| AU2004277403A1 (en) | Polybiotin compounds for magnetic resonance imagining and drug delivery | |
| CN101293878A (zh) | 苯并噻唑苯胺类化合物及其制备方法和应用 | |
| EP3160514A1 (en) | Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging | |
| WO2010125907A1 (ja) | コンフォメーション病診断用組成物 |